{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:42:06Z","timestamp":1791042126772,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1093\/eurheartj\/ehm217","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:14:37Z","timestamp":1182903277000},"page":"2915-2923","source":"Crossref","is-referenced-by-count":107,"title":["Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial"],"prefix":"10.1093","volume":"28","author":[{"given":"Christian","family":"Torp-Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Caterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walmir","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Finer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wygenia","family":"Brisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,6,26]]},"reference":[{"key":"key\n\t\t\t\t20170515123913_EHM217C1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132000","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"key\n\t\t\t\t20170515123913_EHM217C2","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"issue":"Suppl. 1","key":"key\n\t\t\t\t20170515123913_EHM217C3","first-page":"S1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)","volume":"10","author":"European Society of Cardiology Committee for Practice Guidelines","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"key\n\t\t\t\t20170515123913_EHM217C4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515123913_EHM217C5","article-title":"Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515123913_EHM217C6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0025-7125(05)70230-3","article-title":"Behavioral treatment of obesity","volume":"84","year":"2000","journal-title":"Med Clin North Am"},{"key":"key\n\t\t\t\t20170515123913_EHM217C7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t20170515123913_EHM217C8","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515123913_EHM217C9","first-page":"S104","article-title":"Weight loss produced by sibutramine: a meta-analysis","volume":"23","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl. L","key":"key\n\t\t\t\t20170515123913_EHM217C10","first-page":"L39","article-title":"Does pharmacologically induced weight loss improve cardiovascular outcome? Sibutramine pharmacology and the cardiovascular system","volume":"7","year":"2005","journal-title":"Eur Heart J"},{"issue":"Suppl. L","key":"key\n\t\t\t\t20170515123913_EHM217C11","first-page":"L44","article-title":"The SCOUT study: risk-benefit profile of sibutramine in overweight high risk cardiovascular patients","volume":"7","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515123913_EHM217C12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension\u2014European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","author":"Guidelines Committee","year":"2003","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170515123913_EHM217C13","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotension-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","author":"HOPE Study Investigators","year":"1996","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20170515123913_EHM217C14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/hc1002.105136","article-title":"Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?","volume":"105","year":"2002","journal-title":"Circulation"},{"issue":"Suppl.","key":"key\n\t\t\t\t20170515123913_EHM217C15","first-page":"39F","article-title":"Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid-Lowering Arm (ASCOT-LLA)","volume":"96","author":"for the Anglo-Scandinavian Cardiac Outcomes Trial Investigators","year":"2005","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515123913_EHM217C16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ijo.0802574","article-title":"Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study","volume":"28","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t20170515123913_EHM217C17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.ijo.0801677","article-title":"Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet\u2014exercise intervention","volume":"25","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t20170515123913_EHM217C18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-2002-22671","article-title":"Adipositasbehandlung mit Sibutramin unter Praxisbedingungen","volume":"127","year":"2002","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"key\n\t\t\t\t20170515123913_EHM217C19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10286-005-0270-y","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients\u2014sibutramine and blood pressure","volume":"15","year":"2005","journal-title":"Clin Auton Res"},{"key":"key\n\t\t\t\t20170515123913_EHM217C20","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123913_EHM217C21","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1161\/01.CIR.0000072786.99163.FE","article-title":"Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515123913_EHM217C22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clpt.2006.02.002","article-title":"Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects","volume":"79","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170515123913_EHM217C23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","article-title":"Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial","volume":"16","year":"2002","journal-title":"J Hum Hypertens"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/28\/23\/2915\/17048094\/ehm217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T10:16:37Z","timestamp":1503483397000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehm217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,26]]},"references-count":23,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2007,6,26]]},"published-print":{"date-parts":[[2007,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehm217","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,26]]}}}